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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of acupuncture for overweight or obese people.
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B A C K G R O U N D
Description of the condition
Overweight and obesity are defined as abnormal or excessive fat
accumulation that presents a risk to health (WHO 2010). The
fundamental cause of obesity and overweight is an energy imbal-
ance between calories consumed and calories expended. Global
increases in overweight and obesity are attributable to a number of
factors including: a global shift in diet towards increased intake of
energy-dense foods that are high in fat and sugars and a trend to-
wards decreased physical activity due to the increasingly sedentary
nature of many forms of work, changing modes of transportation,
and increasing urbanization. The WHO recommends using the
body mass index (BMI), which is defined as the weight in kilo-
grams divided by the square of the height in meters (kg/m2), to
assess the level of overweight and obesity. At present, the WHO
defines overweight as a BMI equal to or more than 25, and obesity
as a BMI equal to or more than 30. The range of 18.50 to 24.99
is considered as normal. For Asia-Pacific region, the WHO rec-
ommend different ranges (WHO 2000). BMI cut-points provide
a benchmark for individual assessment, but must be regarded as a
rough guide for adults (WHO 2006). The BMI criteria used for
children and teens are different from those used for adults.
In addition to the BMI, there are other measurements, such as
waist circumference and waist-to-hip ratio (WHR), in identifying
individuals at increased risk from obesity-related illness.
The problem of overweight and obesity was labelled as a global
epidemic in the World Health Organization (WHO) report ten
years ago. Evidence is now emerging to suggest that the prevalence
of the global epidemic - “globesity” - is increasing at an alarming
rate in both high-income and middle- and low-income countries
(WHO 2010).
In the European region, prevalence has tripled in many countries
since the 1980s (WHO 2008). The African region has seen an
alarming increase since the early 1990s (WHO 2010). Prevalence
of obesity in the Western Pacific region is well above 20% in
most communities (WHO 2002). In the USA, Colorado is the
only one state having a prevalence less than 20% in 2008 while
32 states had a prevalence equal to or greater than 25% (CDC
2009a). In the South-East Asia region, data suggest that obesity
is growing rapidly in affluent urban populations (WHO 2004).
WHO further projects that by 2015, approximately 2.3 billion
adults will be overweight and more than 700 million will be obese
(WHO 2006).
This is not only happening in the adult population but also in
children and adolescents. According to the latest estimates from
the International Obesity Task Force (IOTF), at least 155 million
school-age children worldwide are overweight. Around 30 to 45
million within that population are classified as obese - accounting
for 2% to 3% of the world’s children aged 5 to 17. A further
22 million children are also affected according to previous IOTF
global estimates based on WHO data for under five years of age
(IOTF 2002). More than 75% of overweight and obese children
live in low- and middle-income countries (WHO 2010).
Obesity has physical, psychological, and social consequences in
adults and children (CDC 2009b). It increases risk of premature
death and debilitating complaints which have an adverse effect on
quality of life. It is also a major risk factor for non communicable
diseases (NCDs) such as non-insulin-dependent diabetes melli-
tus (NIDDM), cardiovascular diseases (CVD) and cancer (WHO
2004). It may also result in many psychological disorders. Besides,
overweight and obesity and their associated health problems lead
to economic burdens to many societies. Obesity has already ac-
counted for 2% to 8% of health costs in several parts of the Eu-
ropean region (WHO 2008); the medical costs of obesity reached
an estimated $147 billion (123 billion EUR, June 2010 estimate)
in the U.S in 2008 (CDC 2009c).
Effective weight management is an important goal for every over-
weight and obese person. Presently, treatments for obesity sug-
gested by the WHO are dietary management, physical activity,
behavior modification, pharmacological treatment, surgery, tradi-
tional medicine and other treatments. Dietary restriction is the
most conventional way for managing weight; adding physical ac-
tivity and exercise to diet is more effective than either method
alone in promoting fat loss; behavior treatment is regarded as an
essential component of any adequate obesity-treatment program.
But all these three treatments have a common limitation, that is
showing short term effects only. The concept of long-term drug
treatment has emerged as an adjunct to other weight-loss therapies
and as a way of helping to maintain body weight over time, how-
ever, its long-term use has raised safety concerns in recent years.
Weight management drugs do not cure obesity, so weight regain
is expected when medication is discontinued. Furthermore, drugs
for weight management have not yet been recommended for rou-
tine use but should be used under medical supervision. Bariatric
surgery is considered to be the most effective way of reducing
weight and may result in a sustained weight loss (WHO 2004).
However, serious complications can occur, so patients should be
selected carefully (Marielle 2008).
Currently, there is an increasing number of people who turn to
complementary and alternative medicine (CAM). Although the
use of acupuncture in the treatment of obesity is relatively new, it
has become one of the most widely used therapies (Cho 2009).
Description of the intervention
Acupuncture originated in China thousands of years ago, consti-
tuting an integral part of Traditional Chinese Medicine (TCM).
TCM, a traditional medical system, represents the wisdom of the
Chinese people as well as a great treasure house of China. Its pro-
found effect appears irreplaceable in maintaining good health of
the Chinese. TCM holds a unique view of the world and the hu-
man body which is different from western medicine concepts. It
has the ’concept of holism’ and ’treatment according to syndrome
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differentiation’. From the viewpoint of TCM, a sound body is
considered as a delicate balance between the two opposing, com-
plementary and inseparable forces, Yin and Yang. The concept of
Yin and Yang is rooted in the ancient Chinese philosophy: Yin rep-
resents cold, slow, weak, dark, or passive aspects, while Yang repre-
sents hot, excited, strong, bright, or active aspects. A major theory
is that health is achieved by maintaining a balance of Yin and Yang
and disease is caused by an imbalance of Yin and Yang (NCCAM
2009). TCM practitioners make a comprehensive analysis of a
patient’s condition by using four diagnostic methods: observing,
hearing and smelling, asking and interviewing, and touching and
palpating as well as applying individual or combined therapies.
As a part of TCM, acupuncture has been practiced in China for
more than 5000 years and gained popularity among Chinese peo-
ple.Over the last fewdecades, its popularity has grown significantly
in the world, spreading first throughout Asia and later to Europe
and the Americas. After thousands of years improving and devel-
oping, today’s acupuncture techniques are quite different from an-
cient times. The term ’acupuncture’, in modern times, describes
the practice of stimulating the specific points on the human body
by penetrating the skin with thin, solid, metallic needles that are
manipulated by the hands, electrical stimulation and so on.
Adverse effects of the intervention
Acupuncture used for treating overweight and obesity is associ-
ated with local pain, inflammation, or occasional infection (Lacey
2003). Relatively few complications have been reported from the
use of acupuncture in general (NCCAM 2009). However, adverse
effects of using acupuncture need to be assessed systematically.
How the intervention might work
Up to now, the mechanism of acupuncture has not been clearly
explained. According toWesternmedicine, the effects of acupunc-
ture are probably the result of stimulating the nervous system to
release chemicals which may in turn release other neurotransmit-
ters or hormones producing the desired effects. This theory is
supported by the basic research work which has shown acupunc-
ture’s effect on adrenocorticotropin (ACTH), insulin, thyroid
hormones, growth stimulating hormone, beta-endorphin, white
blood cell production and plasma cholesterol levels. It is also be-
lieved that acupuncture may work on an electromagnetic bio-in-
formation system (AMFI 2007).
In TCM, acupuncture regulates the balance of Yin and Yang, re-
move blockages of Qi (vital force) and Blood as well as dredge the
meridian to restore and maintain the healthy condition. Being dif-
ferent from the common western understandings, Qi and Blood
are the fundamental substances that maintain the life activities of
the human body. The meridian system is a distribution network
for Qi and Blood, linking different areas of the body together and
making the body an organic whole. Its pathways make up a com-
prehensive yet complex body map that supplies vital energy to ev-
ery part of the body. Acupoints are the specific sites through which
the Qi of the internal organs and meridians is transported to the
body surface. They are classified into three categories: acupoints of
the fourteenmeridians, extraordinary points and Ashi points. Dis-
tributed on their related meridian pathways, acupoints are closely
linked with the meridians. So acupoints should not be regarded
as superficial points alone, but as special sites which connect with
each other, and through which the internal tissues and organs are
related (Li 1999). Using acupuncture to restore and maintain the
internal balance of body is accomplished by acupoint prescription
and acupuncture manipulation.
The earliest written record of overweight and obesity in China
is The Suwen (The Book of Plain Questions). TCM believes
that overweight and obesity is significantly related to phlegm and
dampness, stomach heat, poor spleen functioning, Qi deficiency
and Blood stasis. TCM does not directly reduce excess weight but
holding a holistic concept by dealing with the underlying body
changes which might have bring about the excess weight and fat-
ness. The general principles of practising acupuncture treatment
are worked out under the guidance of the theories of TCM. Ac-
cording to TCM’s understanding of overweight and obesity, the
underlying principles for weight loss treatment are eliminating
phlegm, drying damp, reinforcing spleen and replenishing Qi.
Strengthening the function of the spleen and stomach to carry out
their transformation and transportation properly is the therapeu-
tic principle that TCM adopts in treating overweight and obesity.
Once the body’s balance is restored, the metabolism will process
food properly and excess phlegm and dampness will be resolving.
Excess weight should no longer be a problem.
Why it is important to do this review
Due to the high prevalence of obesity worldwide and increasing
popularity of acupuncture, this review aims to assess the effects of
acupuncture for overweight or obese people. Acupuncture appears
to be effective, safe and convenient in overweight or obese patients,
but scientific evidence of its efficacy and safety is still lacking.
Lacey et al evaluated descriptive and controlled trials of acupunc-
ture for enhancing weight loss (Lacey 2003). This publication pro-
vided a brief overviewof themethods andmechanisms of acupunc-
ture, a summary of descriptive and controlled studies of acupunc-
ture in the treatment of obesity and an agenda for future research.
Pittler et al aimed to assess the evidence fromRCTs and systematic
reviews of complementary therapies for reducing body weight (
Pittler 2005). The evidence related to acupuncture and acupressure
(one systematic review and three RCTs) were also included and
reviewed. The authors found that acupuncture or acupressure for
reducing body weight was not convincing.
Currently, there are three systematic reviews and meta-analyses of
the evidence on the effects of acupuncture for overweight or obese
people (Cho 2009; Lin 2009; Yu 2010):
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The aim of the first systematic review by Cho et al was to assess the
effects on body weight reduction after acupuncture and to evaluate
adverse events of this therapy based on the results of RCTs that
evaluated various types of acupuncture therapies (Cho 2009). It
suggested that acupuncture is an effective treatment for obesity.
However, the amount of evidence was not fully convincing because
of the poor methodological quality of trials reviewed.
The aim of the second systematic review was to evaluate the effects
of acupuncture for treating obesity and to analyze the current
situation of clinical studies (Lin 2009). The review concluded
that besides reasonable diet and exercise, acupuncture was safe
and effective for treating obesity. It may be more effective than
pharmacological treatment. Because the quantity of literature was
limited and the quality of some publications was low, more high-
quality and large-scale RCTs are needed.
The aim of the third systematic review was to investigate the ef-
fects of acupuncture in treating obesity (Yu 2010). Results sug-
gested that acupuncture may have certain advantages over routine
medical treatment. As the quality of some studies was low, definite
conclusions could not be obtained.
However, the previous systematic reviews have some limitations.
For example, firstly, search strategies have not been documented
clearly andmost of the search strategies were not conducted up-to-
date, therefore it is possible that relevant studies were overlooked
and recent trials were not included. Secondly, the methodological
quality of reviews appeared not to be rigorously controlled by a
methodology panel and editorial team. Moreover, these publica-
tions can not be updated easily and reviewers can not change or
adapt searches, methods, outcomes, conclusions and so on.
O B J E C T I V E S
To assess the effects of acupuncture for overweight or obese people.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials, quasi-randomized trials and con-
trolled clinical trials.
Types of participants
Male or female patients of any age or ethnic origin who are over-
weight or obese will be eligible. The diagnosis of overweight and
obese should preferably be consistent with the WHO definition.
However, Studies used other general accepted standard will be also
included.
Diagnostic criteria
The WHO defines overweight in adult Euroeans as a body mass
index (BMI) equal to or more than 25 (kg/m2), and obesity as a
BMI equal to or more than 30; in Asians, overweight is defined as
a BMI equal to or more than 23 and obesity as a BMI equal to or
more than 25.
Diagnostic criteria will be potentially subjected to a sensitivity
analysis.
Types of interventions
Intervention
Acupuncture. Acupuncture involves the act of needle insertion, al-
though there aremany other non-invasive techniques for acupunc-
ture point stimulation. Points may be selected according to tra-
ditional medical systems, symptoms, point selection based on the
scientific relationships of point function and point prescription.
Methods of stimulating acupoints which are quite different from
traditional acupuncture, such as laser acupuncture and surface
electrodes, will be excluded.
Control
No intervention, placebo acupuncture, sham acupuncture, phar-
macological treatments, or other non-acupuncture interventions.
Trials comparing acupuncture plus non-acupuncture treatment
with the same non-acupuncture treatment will be also included.
Trials that only compare different forms of acupuncture or differ-
ent acupoints will be excluded.
Types of outcome measures
Primary outcomes
• measures of weight or obesity, fat content or fat distribution
(such as kg, body mass index, waist-to-hip ratio and fat free
mass);
• morbidity (such as hypertension, coronary heart disease,
diabetes mellitus and insulin resistance).
Secondary outcomes
• change in risk factors (such as blood pressure, lipid profile
and glycosylated haemoglobin A1c (HbA1c));
• recurrence rate;
• adverse effects (such as local pain, inflammation and
infection);
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• physical activity;
• quality of life measures;
• costs.
Possible covariates, effect modifiers and confounders
• compliance with the treatment;
• co-morbidities such as cancer, diabetes mellitus and
respiratory disease that may cause weight loss or increase.
Timing of outcome measurement
• short-term: more than two weeks to twelve weeks;
• medium-term: more than twelve weeks to six months;
• long-term: more than six months.
Search methods for identification of studies
Electronic searches
We will use the following sources for the identification of trials:
• The Cochrane Library (until recent);
• MEDLINE (until recent);
• EMBASE (until recent);
• AMED (until recent);
• CBM (Chinese Biomedical Medicine Database) (until
recent);
• CNKI (China National Knowledge Infrastructure) (until
recent);
• VIP (VIP Database for Chinese Technical Periodicals)
(until recent);
• Digital Journal of Wanfang Data (until recent).
Wewill also search databases of ongoing trials: ’CurrentControlled
Trials’ (www.controlled-trials.com - with links to other databases
of ongoing trials).
For detailed search strategies see under Appendix 1.
Additional key words of relevance may be detected during any of
the electronic or other searches. If this is the case, electronic search
strategies will be modified to incorporate these terms. Studies pub-
lished in any language will be included.
Publications not in English or Chinese will be translated with the
help of the Cochrane Metabolic and Endocrine Disorders Group.
Searching other resources
Wewill try to identify additional studies by searching the reference
lists of included trials and (systematic) reviews, meta-analyses and
health technology assessment reports noticed.
Data collection and analysis
Selection of studies
To determine the studies to be assessed further, two authors (YL,
GL) will independently scan the abstract, title or both sections of
every record retrieved. All potentially relevant articles will be inves-
tigated as full text. Interrater agreement for selection of potentially
relevant studies will be measured using the kappa statistic (Cohen
1960). Differences will be marked and if these studies are later
on included, the influence of the primary choice will be subjected
to a sensitivity analysis. Where differences in opinion exist, they
will by resolved by a third party. If resolving disagreement is not
possible, the article will be added to those ’awaiting assessment’
and authors will be contacted for clarification. We will attach an
adapted PRISMA (preferred reporting items for systematic reviews
and meta-analyses) flow-chart of study selection (Liberati 2009).
Data extraction and management
For studies that fulfil inclusion criteria, two authors (YL, GL)
will independently abstract relevant population and intervention
characteristics using standard data extraction templates (for details
see ’Characteristics of included studies, Table 1, Appendix 2,
Appendix 3, Appendix 4, Appendix 5) with any disagreements
to be resolved by discussion, or if required by a third party. Any
relevant missing information on the trial will be sought from the
original author(s) of the article, if required.
Interventions will be reported according to the standards for
reporting clinical trials of acupuncture (STRICTA) (STRICTA
2010).
Dealing with duplicate publications
In the case of duplicate publications and companion papers of a
primary study, we will try to maximise yield of information by
simultaneous evaluation of all available data. In cases of doubt,
the original publication (usually the oldest version) will obtain
priority.
Assessment of risk of bias in included studies
Two authors (YL, GL) will assess each trial independently. Possible
disagreements will be resolved by consensus, or with consultation
of a third party. Interrater agreement for key bias indicators (e.g.
allocation concealment, incomplete outcome data) will be calcu-
lated using the kappa statistic (Cohen 1960). In cases of disagree-
ment, the rest of the group will be consulted and a judgement will
be made based on consensus.
We will assess risk of bias using the Cochrane Collaboration’s tool
(Higgins 2009). We will use the following criteria:
• was the allocation sequence adequately generated?
• was the allocation adequately concealed?
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• was knowledge of the allocated intervention adequately
prevented during the study?
• were incomplete outcome data adequately addressed?
• were reports of the study free of suggestion of selective
outcome reporting?
• was the study apparently free of other problems that could
put it at a high risk of bias?
A judgement of ‘Yes’ indicates low risk of bias, ‘No’ indicates high
risk of bias and ‘Unclear’ indicates unclear or unknown risk of
bias. We will use these criteria for a judgement of ‘Yes’, ‘No’ and
‘Unclear’ for individual bias items as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2009).
A ’risk of bias graph’ figure and ’risk of bias summary’ figure will
be attached.
We will assess the impact of individual bias domains on study
results at endpoint and study levels.
Measures of treatment effect
Dichotomous data will be expressed as odds ratio (OR) or risk
ratio (RR) with 95% confidence intervals (CI). Continuous data
will be expressed as weighted differences in means (WMD) with
95% CI.
Unit of analysis issues
We will take into account the level at which randomisation oc-
curred, such as cross-over trials, cluster-randomised trials andmul-
tiple observations for the same outcome.
Dealing with missing data
We will obtain relevant missing data from authors, if feasible and
carefully perform evaluation of important numerical data such as
screened, randomised patients as well as intention-to-treat (ITT),
as-treated and per-protocol (PP) populations. We will investigate
attrition rates, for example drop-outs, losses to follow up and
withdrawals and critically appraise issues of missing data and im-
putation methods (for example last-observation-carried-forward
(LOCF)).
Assessment of heterogeneity
In the event of substantial clinical or methodological or statistical
heterogeneity we will not report study results as meta-analytically
pooled effect estimates. We will identify heterogeneity by visual
inspection of the forest plots and by using a standard Chi2 test
with a significance level of α = 0.1, in view of the low power of
this test. We specifically will examine heterogeneity employing the
I2 statistic which quantifies inconsistency across studies to assess
the impact of heterogeneity on the meta-analysis (Higgins 2002;
Higgins 2003), where an I2 statistic of 75% and more indicates a
considerable level of inconsistency (Higgins 2009).
When heterogeneity is found, we will attempt to determine po-
tential reasons for it by examining individual study and subgroup
characteristics.
Assessment of reporting biases
Funnel plots will be used to assess for the potential existence of
small study bias. There are a number of explanations for the asym-
metry of a funnel plot (Sterne 2001). Therefore, we will carefully
interpret results (Lau 2006).
Data synthesis
Data will be summarised statistically if they are available, suffi-
ciently similar and of sufficient quality. We will perform statistical
analyses according to the statistical guidelines referenced in the
newest version of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2009).
Subgroup analysis and investigation of heterogeneity
We will mainly carry out subgroup analyses if one of the primary
outcome parameters demonstrates statistically significant differ-
ences between intervention groups. In any other case subgroup
analyses will be clearly marked as a hypothesis generating exercise.
The following subgroup analyses are planned:
• degree of overweight or obesity (depending on data);
• age (depending on data);
• gender.
Sensitivity analysis
We will perform sensitivity analyses in order to explore the influ-
ence of the following factors on effect size:
• repeating the analysis excluding unpublished studies;
• repeating the analysis taking account risk of bias, as
specified above;
• repeating the analysis excluding very long or large studies to
establish how much they dominate the results;
• repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), country.
We will also test the robustness of the results by repeating the
analysis using different measures of effect size (relative risk, odds
ratio etc.) anddifferent statisticalmodels (fixed-effect and random-
effects models).
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A D D I T I O N A L T A B L E S
Table 1. Overview of study populations
Study ID Interven-
tion(s) &
control(s)
[n] screened [n]
randomised
[n] safety [n] ITT [n] finish-
ing study
[%] of ran-
domised
partici-
pants
finishing
study
Comments
ID1 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID2 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID3 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID3 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
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Table 1. Overview of study populations (Continued)
ID4 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID5 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID6 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID7 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID8 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
ID9 I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Total I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
C: control; I: intervention; ITT: intention-to-treat
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A P P E N D I C E S
Appendix 1. Search strategies
Search terms
Unless otherwise stated, search terms are free text terms; MeSH = Medical subject heading (MEDLINE medical index term); exp =
exploded MeSH; the dollar sign ($) stands for any character(s); the question mark (?) substitutes one or no characters; tw = text word;
pt = publication type; sh = MeSH; adj = adjacent
The Cochrane Library
#1 MeSH descriptor Obesity explode all trees
#2 MeSH descriptor Weight Gain explode all trees
#3 MeSH descriptor Weight Loss explode all trees
#4 MeSH descriptor Body Mass Index explode all trees
#5 (overweight in All Text or (over in All Text and weight in All Text) )
#6 (adipos* in All Text or (fat in All Text and overload in All Text and syndrom* in All Text)
#7 (overeat* in All Text or (over in All Text and eat* in All Text) )
#8 (overfeed* in All Text or (over in All Text and feed* in All Text) )
#9 (weight in All Text and (cycl* in All Text or reduc* in All Text or los* in All Text or maint* in All Text or (decreas*or in All Text
and watch* in All Text) or control* in All Text)
#10 (weight in All Text and (gain in All Text or chang* in All Text) )
#11 (body in All Text and mass in All Text and ind* in All Text)
#12 MeSH descriptor Skinfold thickness explode all trees
#13 MeSH descriptor Waist-Hip Ratio explode all trees
#14 MeSH descriptor Abdominal fat explode all trees
#15 MeSH descriptor Overweight explode all trees
#16 (adipos* in All Text or obes* in All Text)
#17 (waist-hip in All Text and ratio* in All Text)
#18 ( (skinfold in All Text and thickness* in All Text) or (abdominal in All Text and fat* in All Text)
#19 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18)
#20 MeSH descriptor Acupuncture explode all trees
#21 MeSH descriptor Acupuncture therapy explode all trees
#22 MeSH descriptor Acupressure explode all trees
#23 (acupuncture in All Text or acupressure in All Text or acupoint in All Text)
#24 MeSH descriptor Electroacupuncture explode all trees
#25 (electro-acupuncture in All Text or electroacupuncture in All Text)
#26 (#20 or #21 or #22 or #23 or #24 or #25)
#27 (#19 and #26)
Ovid MEDLINE
1. exp Acupuncture/
2. exp Acupuncture Therapy/
3. exp Acupressure/
4. (acupuncture or acupressure or acupoint).tw,ot.
5. exp Electroacupuncture/
6. (electro-acupuncture or electroacupuncture).tw,ot.
7. or/1-6
8. exp Obesity/
9. exp weight gain/ or exp weight loss/
10. exp body mass index/ or exp skinfold thickness/ or exp waist-hip ratio/
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(Continued)
11. exp Abdominal Fat/
12. exp Overweight/
13. (overweight$ or over weight$).tw,ot.
14. fat overload syndrom$.tw,ot.
15. (overeat$ or over eat$).tw,ot.
16. (overfeed$ or over feed$).tw,ot.
17. (adipos$ or obes$).tw,ot.
18. (weight adj3 (cyc$ or reduc$ or los$ or maint$ or decreas$ or watch$ or control$ or gain$ or chang$)).tw,ot.
19. (body mass ind$ or waist-hip ratio$).tw,ot.
20. skinfold thickness$.tw,ot.
21. abdominal fat$.tw,ot.
22. or/8-21
23. 7 and 22
24. randomized controlled trial.pt.
25. controlled clinical trial.pt.
26. randomi?ed.ab.
27. placebo.ab.
28. drug therapy.fs.
29. randomly.ab.
30. trial.ab.
31. groups.ab.
32. or/24-31
33. Meta-analysis.pt.
34. exp Technology Assessment, Biomedical/
35. exp Meta-analysis/
36. exp Meta-analysis as topic/
37. hta.tw,ot.
38. (health technology adj6 assessment$).tw,ot.
39. (meta analy$ or metaanaly$ or meta?analy$).tw,ot.
40. ((review$ or search$) adj10 (literature$ or medical database$ or medline or pubmed or embase or cochrane or cinhal or psychinfo
or psychlit or healthstar or biosis or current content$ or systemat$)).tw,ot.
41. or/33-40
42. (comment or editorial or historical-article).pt.
43. 41 not 42
44. 32 or 43
45. 23 and 44
46. (animals not (animals and humans)).sh.
47. 45 not 46
EMBASE
1. exp acupuncture/
2. exp acupressure/
3. exp electroacupuncture/
4. (acupuncture or acupressure or acupoint).tw,ot.
5. (electro-acupuncture or electroacupuncture).tw,ot.
6. or/1-5
7. exp Obesity/
8. exp weight change/ or exp weight control/ or exp weight gain/ or exp weight reduction/
9. exp body mass/ or exp waist circumference/ or exp waist hip ratio/
10. (obes$ or overweight or over weight).ab,ti.
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(Continued)
11. (overeat or over eat or overfeed or over feed or fat overload syndrom$).ab,ti.
12. (weight adj6 (cyc$ or reduc$ or los$ or maint$ or decreas$ or watch$ or control or chang$ or gain)).ab,ti.
13. (body mass ind$ or waist hip ratio or waist circumferenc$).ab,ti.
14. adipos$.ab,ti.
15. exp skinfold thickness/
16. (abdominal fat or skinfold thickness).ab,ti.
17. exp skinfold thickness/
18. exp abdominal fat/
19. or/7-18
20. 6 and 19
21. exp Randomized Controlled Trial/
22. exp Controlled Clinical Trial/
23. exp Clinical Trial/
24. exp Comparative Study/
25. exp Drug comparison/
26. exp Randomization/
27. exp Crossover procedure/
28. exp Double blind procedure/
29. exp Single blind procedure/
30. exp Placebo/
31. exp Prospective Study/
32. ((clinical or control$ or comparativ$ or placebo$ or prospectiv$ or randomi?ed) adj3 (trial$ or stud$)).ab,ti.
33. (random$ adj6 (allocat$ or assign$ or basis or order$)).ab,ti.
34. ((singl$ or doubl$ or trebl$ or tripl$) adj6 (blind$ or mask$)).ab,ti.
35. (cross over or crossover).ab,ti.
36. or/21-35
37. exp meta analysis/
38. (metaanaly$ or meta analy$ or meta?analy$).ab,ti,ot.
39. ((review$ or search$) adj10 (literature$ or medical database$ or medline or pubmed or embase or cochrane or cinhal or psychinfo
or psychlit or healthstar or biosis or current content$ or systematic$)).ab,ti,ot.
40. exp Literature/
41. exp Biomedical Technology Assessment/
42. hta.tw,ot.
43. (health technology adj6 assessment$).tw,ot.
44. or/37-43
45. (comment or editorial or historical-article).pt.
46. 44 not 45
47. 36 or 46
48. 20 and 47
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Appendix 2. Description of interventions
Charac-
teristic
study ID1 study ID2 study ID3 study ID4 study ID5 study ID6 study ID7 study ID8 study ID9
Interven-
tion(s)
[route, fre-
quency, to-
tal dose/
day]
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
I1:
I2:
Control(s)
[route, fre-
quency, to-
tal dose/
day]
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
C1:
C2:
Footnotes
C: control; I: intervention
Appendix 3. Baseline characteristics
Charac-
teristic
study ID1 study ID2 study ID3 study ID4 study ID5 study ID6 study ID7 study ID8 study ID9
Interven-
tion(s) &
control(s)
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Participat-
ing popu-
lation
Sex
[female% /
male%]
Age [mean
years (SD)]
Dura-
tion of dis-
ease [mean
years (SD)]
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(Continued)
Ethnic
groups [%]
Dura-
tion of in-
tervention
Dura-
tion of fol-
low up
Footnotes
C: control; I: intervention
Appendix 4. Matrix of study endpoints
Charac-
teristic
study ID1 study ID2 study ID3 study ID4 study ID5 study ID6 study ID7 study ID8 study ID9
Interven-
tion(s) &
control(s)
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Primary
1 endpoint
(s)
Secondary
2 endpoint
(s)
Other
3 endpoint
(s)
Footnotes
1,2 as stated in the publication; 3 not stated as primary or secondary endpoint(s) in the publication
C: control; I: intervention
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Appendix 5. Adverse events
Charac-
teristic
study ID1 study ID2 study ID3 study ID4 study ID5 study ID6 study ID7 study ID8 study ID9
Interven-
tion(s) &
control(s)
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
I1:
I2:
C1:
C2:
Deceased
partici-
pants [n]
I1: n / N
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Adverse
events [n /
%]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Serious ad-
verse
events [n /
%]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Drop-
outs due to
adverse
events [n /
%]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Hospital-
isation [n /
%]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Out-pa-
tient treat-
ment [n /
%]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
Symptoms
[n / %]
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
I1:
I2:
C1:
C2:
Total:
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(Continued)
Footnotes
C: control; I: intervention
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